Telmisartan Tablet
FDA Label NDC 65841-805

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Telmisartan (NDC 65841-805). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-804-05 in bottle of 500 tablets

Telmisartan Tablets USP, 20 mg

Rx only

500 tablets

Telmisartan Tablets, 20 mg (D1a66435 27b3 4f7b 9b01 A17c8cdc27ee 04)

Telmisartan Tablets, 20 mg (D1a66435 27b3 4f7b 9b01 A17c8cdc27ee 04)

NDC 65841-805-05 in bottle of 500 tablets

Telmisartan Tablets USP, 40 mg

Rx only

500 tablets

Telmisartan Tablets, 40 mg (D1a66435 27b3 4f7b 9b01 A17c8cdc27ee 05)

Telmisartan Tablets, 40 mg (D1a66435 27b3 4f7b 9b01 A17c8cdc27ee 05)

NDC 65841-806-05 in bottle of 500 tablets

Telmisartan Tablets USP, 80 mg

Rx only

500 tablets

Telmisartan Tablets, 80 mg (D1a66435 27b3 4f7b 9b01 A17c8cdc27ee 06)

Telmisartan Tablets, 80 mg (D1a66435 27b3 4f7b 9b01 A17c8cdc27ee 06)

* Please review the disclaimer below.